Related Experiment Video
Updated: Sep 17, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
An example of long-term remission in oligorecurrent relapsed small-cell lung cancer, following single modality
Natalie Shammas1, Sajjad Bhatti2
1Internal Medicine, CHI Saint Vincent Health System, Little Rock, Arkansas, USA.
Abstract:
Limited-stage small-cell lung cancer (LS-SCLC) is treated with curative intent; however, relapses are common. Relapsed disease is typically treated with systemic therapy with palliative intent. However, some patients with oligorecurrent presentation may benefit from aggressive local therapy with a potential chance of long-term remission. In this case report, we review the case of a patient diagnosed with LS-SCLC after a thorough diagnostic and staging workup. She received 4 cycles of systemic chemotherapy, along with concurrent radiation therapy, followed by prophylactic cranial irradiation (PCI). Unfortunately, she developed two small metachronous brain metastases, 3 months and 12 months after PCI. Given no other disease activity on CT and subsequent positron emission tomography, she received stereotactic radiosurgery without systemic therapy. She remains in remission for >3 years with no evidence of disease without any need for ongoing active systemic therapy.
Related Concept Videos
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

